Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Adrb2em1/Cya
Common Name:
Adrb2-KO
Product ID:
S-KO-00947
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Adrb2-KO
Strain ID
KOCMP-11555-Adrb2-B6J-VA
Gene Name
Adrb2
Product ID
S-KO-00947
Gene Alias
Adrb-2; Badm; Gpcr7
Background
C57BL/6JCya
NCBI ID
11555
Modification
Conventional knockout
Chromosome
18
Phenotype
MGI:87938
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Adrb2em1/Cya mice (Catalog S-KO-00947) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000053640
NCBI RefSeq
NM_007420
Target Region
Exon 1
Size of Effective Region
~2.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Adrb2, also known as the beta-2 adrenergic receptor, is a crucial component of the adrenergic signaling pathway. It plays a significant role in regulating various physiological processes and is involved in multiple disease-related pathways. Activation of Adrb2 has been associated with anti-apoptotic mechanisms in cancer cells, and it also participates in pathways related to cell proliferation, autophagy, and metastasis [1,2,3]. Genetic models, such as gene knockout (KO) or conditional knockout (CKO) mouse models, can be valuable for studying Adrb2's function in vivo.

In multiple cancer types, research has revealed important roles of Adrb2. In prostate cancer, Adrb2 signaling contributes to tumor progression and therapy resistance through anti-apoptotic mechanisms, and understanding its signaling in the context of other pathways can help identify patients who may benefit from propranolol therapy [1]. In hepatocellular carcinoma (HCC), Adrb2 signaling promotes cancer cell proliferation, survival, and sorafenib resistance by inhibiting autophagic degradation of HIF1α, and its inhibition can enhance anti-tumor activity of sorafenib [2]. In gastric cancer, stress-hormone induced activation of Adrb2 signaling pathway is crucial for cancer progression and metastasis, and Adrb2 antagonists can suppress these processes by inhibiting relevant MAPK pathways and transcription factors [3]. In gastrointestinal stromal tumor (GIST), high Adrb2 expression is associated with risk level, tumor size, mitotic count, and metastasis, and it promotes GIST cell proliferation, migration, invasion, and apoptosis by enhancing the ETV1-c-KIT signaling [5]. Additionally, in chimeric antigen receptor (CAR)-T cell therapy against prostate cancer, downregulating Adrb2 in CAR-T cells via RNA interference improves their anti-tumor functions [4].

In conclusion, Adrb2 is a key player in the adrenergic signaling pathway with significant implications in cancer biology. Model-based research, especially KO/CKO mouse models, could potentially further elucidate its role in cancer and other diseases. Understanding Adrb2's function provides insights into potential therapeutic strategies, such as the use of beta-blockers or targeting Adrb2-related pathways in treating various cancers.

References:

1. Kulik, George. 2019. ADRB2-Targeting Therapies for Prostate Cancer. In Cancers, 11, . doi:10.3390/cancers11030358. https://pubmed.ncbi.nlm.nih.gov/30871232/

2. Wu, Fu-Quan, Fang, Tian, Yu, Le-Xing, Yang, Wen, Wang, Hong-Yang. 2016. ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α. In Journal of hepatology, 65, 314-24. doi:10.1016/j.jhep.2016.04.019. https://pubmed.ncbi.nlm.nih.gov/27154061/

3. Zhang, Xuan, Zhang, Yi, He, Zhongyuan, Zhang, Lu, Xu, Zekuan. 2019. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2. In Cell death & disease, 10, 788. doi:10.1038/s41419-019-2030-2. https://pubmed.ncbi.nlm.nih.gov/31624248/

4. Ajmal, Iqra, Farooq, Muhammad Asad, Duan, Yixin, Du, Bingtan, Jiang, Wenzheng. 2024. Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 3539-3557. doi:10.1016/j.ymthe.2024.08.028. https://pubmed.ncbi.nlm.nih.gov/39228124/

5. Chen, Sijun, Wu, Feijing, Zhang, Jiaxuan, Zhou, Xiaorong, Zhi, Xiaofei. 2023. ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling. In Journal of oncology, 2023, 6413796. doi:10.1155/2023/6413796. https://pubmed.ncbi.nlm.nih.gov/36778918/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest